Open AccessEffect of inhaled budesonide/formoterol fumarate dihydrate delivered via two different devices on lung function in patients with COPD and low peak inspiratory flow
Author(s) -
Bärbel Huber,
Claus Keller,
Martin Jenkins,
Abid Raza,
Magnus Aurivillius
Publication year - 2022
Publication title -
therapeutic advances in respiratory disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.022
H-Index - 37
eISSN - 1753-4666
pISSN - 1753-4658
DOI - 10.1177/17534666221107312
Subject(s) - medicine , budesonide , formoterol , copd , adverse effect , budesonide/formoterol , crossover study , dry powder inhaler , formoterol fumarate , anesthesia , inhalation , pulmonary function testing , tiotropium bromide , asthma , inhaler , lung , lung function , placebo , alternative medicine , pathology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom